Brief: PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention
18/06/2024 12:14
June 18 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID HOSTS KOL CALL TO DISCUSS SIGNIFICANT UNMET
MEDICAL NEED
IN SURGICAL SITE INFECTIONS PREVENTION AND PROVIDES UPDATE ON
ITS ONGOING SHIELD II PHASE 3 TRIAL
* POLYPID LTD: TOP-LINE RESULTS EXPECTED IN Q1 OF 2025
Source text for Eikon: ID:nGNX5GBGk9
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA